The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Change in cardiac function with CPX-351 in relapsed pediatric AML: A Children’s Oncology Group (COG) report from AAML1421.
 
Kasey J. Leger
Consulting or Advisory Role - BTG; Jazz Pharmaceuticals
Research Funding - Abbott Laboratories
Travel, Accommodations, Expenses - BTG; Jazz Pharmaceuticals
 
Michael Absalon
Research Funding - Jazz Pharmaceuticals (Inst)
 
Biniyam G Demissei
No Relationships to Disclose
 
Robert B Gerbing
No Relationships to Disclose
 
Todd Allen Alonzo
No Relationships to Disclose
 
Betsy A Hirsch
No Relationships to Disclose
 
Jessica Anne Pollard
No Relationships to Disclose
 
Bassem I. Razzouk
No Relationships to Disclose
 
E. Anders Kolb
Travel, Accommodations, Expenses - Roche/Genentech
 
Richard Aplenc
Honoraria - Sigma-Tau
Expert Testimony - Wiggin and Dana
Travel, Accommodations, Expenses - Sigma-Tau
 
Bonnie Ky
Honoraria - UpToDate
Consulting or Advisory Role - American College of Cardiology; Bioinvent; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Gilead Sciences; Mateon Therapeutics; Roche; Roche
Speakers' Bureau - Bristol-Myers Squibb
Research Funding - Pfizer; Roche; Singulex
Patents, Royalties, Other Intellectual Property - Have a patent on the use of neuregulin-1b as a biomarker in heart failure; Pending patent application on the use of IgE as a biomarker of cardiotoxicity
 
Todd Michael Cooper
Employment - Juno/Celgene (I)
Stock and Other Ownership Interests - Juno/Celgene (I)